Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Vascular Diseases

• Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma
• Impact of SGLT2 Inhibitors in Heart Transplant Recipients
• Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
• Optimal Blood Pressure Treatment Thresholds Postpartum
• Selective Spinal Anaesthesia With Hyperbaric Prilocain With 2%Provides Better Perioperative Hemodynamic Stability for Patients With Peripheral Vascular Disease and Cardiac Dysfunction in Lower Limb Surgery
• A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Disease
• SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery
• Tranexamic Acid Administration Strategies in Cardiovascular Surgery: Goal-directed vs. Empirical Tranexamic Acid Administration
• Does Increasing Oxygen Nurture Your Symptomatic Ischemic Ulcer Sufficiently?
• A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD)
• Multicenter, Uncontrolled Pilot Study Evaluating the Efficacy of Eculizumab in the Treatment of Gemcitabine-induced Thrombotic Microangiopathies
• Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy
• The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy
• Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)
• Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH
• Adjunct Episcleral Brachytherapy for PCV
• Statin Intensity and Coronary Allograft Vasculopathy After Heart Transplantation
• Drug Eluting Balloon (DEB) vs Plain Old Balloon Angioplasty (POBA) in the Treatment of Failing Dialysis Access
• For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
• The Effects of Oral Inorganic Nitrate Supplementation on Lower Limb Perfusion During Exercise in Patients With PAD
• Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients
• A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology
• Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection
• The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
• Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
• Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy
• The Effects of Iontophoresed Vasoactive Drugs on Cutaneus Blood Flow
• Antiplatelet Therapy in Heart Transplantation
• Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept
• Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)
• Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL)
• Study of Ravulizumab in Pediatric Participants With HSCT-TMA
• Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant
• Crizanlizumab for Treating COVID-19 Vasculopathy
• Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy
• Contribution of Dolutegravir to Obesity and Cardiovascular Disease
• A Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction
• Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease
• Topical Gentamicin and Vancomycin for Vascular Surgical Site Infection Prophylaxis
• Efficacy and Safety Of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy in Recent Heart Transplant Recipients
• Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
• A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH
• Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid
• Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
• Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients
• The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions
• Nitrite Effects on Cardiac Muscle in CABG
• 11C-PIB PET Study in MESA at Columbia University
• Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment
• Carnosine for Peripheral Vascular Disease
• The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease
• Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
• Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients
• Effect of Changing Physiological Conditions on Myogenic Oscillations: Pilot Study
• A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
• A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
• Comfort and Antimicrobial Efficacy of Chlorhexidine vs Betadine for Intravitreal Injections
• Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
• Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen
• Fluoxetine Opens Window to Improve Motor Recovery After Stroke
• Taurine Supplementation on Lower Extremity Vasculopathy in Patients With Diabetes
• Effect of Ivabradine on Exercise Capacity After Heart Transplantation
• Peripheral Nerve Blocks for Above-the-knee Amputations
• Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
• Defibrotide TMA Prophylaxis Pilot Trial
• ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
• Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
• Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular Disease
• Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After Surgery
• A Safety and Efficacy Study of NAC in Patients With TA-TMA
• Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy
• Coronary Artery Vasculopathy in Pediatric Heart Transplant Patients
• Subclinical Cardiovascular Disease in Psoriatic Disease
• Influence of Vorapaxar on Thrombin Generation and Coagulability
• The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)
• A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease
• An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy
• Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging
• Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs
• Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers
• Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy
• The Effect of Anacetrapib on Vascular Function and Arterial Stiffness
• Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.
• Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
• Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy
• Initial Versus Delayed PDT Combination With Conbercept in PCV
• Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging
• Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy
• Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy
• Efficacy and Safety of LFG316 in Transplant Associated Microangiopathy (TAM) Patients
• Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
• PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept
• General Anesthesia for Endovascular Thrombectomy; A Pilot Study.
• Assessment of Short-term Effect of L-Citrulline on Endothelial Function and Vasodilation in Known CAD Patients
• Influence of Vorapaxar on Thrombin Generation and Coagulability
• Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CF
• Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants
• Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy
• Is Peri-operative Hyperoxemia a Risk Factor for Postoperative Complications?
• Changes in Myocardial Biomechanics and Early Short-term Doxycycline Therapy in Patients With Primary Anterior STEMI
• Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
• Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment
• Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy
• A Study to Establish the Safety and Tolerability of Zimura® (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
• Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment
• Exparel as a Nerve Block for Severe Hand Pain
• Dynamic Assessment of Right Ventricular Function With Inhaled Nitric Oxide During Cardiac MRI
• Colchicine in Vascular Inflammation Assessed With PET Imaging
• 3 Month PHI PAD PoM Study
• Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients
• Aflibercept in Polypoidal Choroidal Vasculopathy
• Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial)
• Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy
• The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation
• Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD
• Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)
• ICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot Study
• Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy
• Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)
• Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation
• Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation
• Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT)
• Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
• Phosphodiesterase-5 (PDE-5) Inhibition in Heart Transplant Recipients
• Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH)
• Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors
• Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy
• Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
• Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
• Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease
• Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose
• Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
• Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy
• Effects of Paclitaxel on Intimal Hyperplasia
• Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients
• Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol
• Study to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without Pottasium
• Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy
• Gadobutrol Enhanced MRA of the Supra-aortic Vessels
• iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)
• Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients
• Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
• SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance
• REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification
• Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy
• Bosentan for Mild Pulmonary Vascular Disease in Asd Patients.
• Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation
• A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV)
• Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty
• XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
• Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 3)
• Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers (Protocol 2)
• PF-00489791 For The Treatment Of Raynaud's
• Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy
• Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers
• Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)
• VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
• Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy
• A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome
• Simvastatin for Treating Erectile Dysfunction
• Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
• Gap Junction Potentiation of Endothelial Function With Rotigaptide
• Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
• Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People
• Study of Post-meal Blood Sugar Peaks in Association With Vascular Disease in Childhood Obesity
• Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy
• Evaluation of Cilostazol in Combination With L-Carnitine
• Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease
• Nadroparin for the Initial Treatment of Pulmonary Thromboembolism
• Platelet Hyperreactivity to Aspirin and Stroke
• Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy
• Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED)
• Assessment of Oxygen Changes in the Heart With Cardio-vascular Magnetic Resonance Imaging
• A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED)
• Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy
• Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)
• Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)
• Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography
• Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia
• Effect of Thiazolidinedione Treatment Vascular Risk Markers
• Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis
• Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients Transplant
• Prevention of Restenosis Following Revascularization
• Testosterone for Peripheral Vascular Disease
• To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients
• Sevelamer, Fetuin-A and Endothelial Dysfunction in CKD
• Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
• Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)
• Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets
• Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease
• Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)
• Crossover Study With MultiHance vs a Comparator for Peripheral MRA
• Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)
• Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients
• RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
• Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy
• Testosterone Replacement in Diabetes With Vascular Disease (Version 2)
• Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy
• Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery
• Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia
• Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy
• Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease
• L-Arginine in the Treatment of Peripheral Arterial Disease
• Markers and Mechanisms of Vascular Disease in Type II Diabetes
• PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients
• Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia
• Aldosterone and Vascular Disease in Diabetes Mellitus
• Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries
• Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel
• Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures
• Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes
• Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)
• Warfarin and Antiplatelet Vascular Evaluation
• Rosiglitazone Plaque Study
• Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease
• Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease
• Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication
• Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy
• Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)
• Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
• The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC
• Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft
• Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication
• Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
• Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
• Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
• Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease
• Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures
• Extract of Ginkgo Biloba (EGB 761) and Vascular Function
• Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
• Prevention of Recurrent Venous Thromboembolism (PREVENT)
• Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
• Oral Calcium in Pregnant Women With Hypertension
• Arterial Disease Multifactorial Intervention Trial (ADMIT)
• Calcium for Pre-Eclampsia Prevention (CPEP)
• Raynaud's Treatment Study (RTS)
• Recurrent Carotid Stenosis
• Treatment of Mild Hypertension Study (TOMHS)
• Trial of Antihypertensive Intervention Management
• Cardiovascular System in Obesity: Effect of Treatment
• Hypertension Prevention Trial (HPT) Feasibility Study
• Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
• Control of Hypertension by Non-Pharmacologic Means
• Hypertension Detection and Follow-up Program (HDFP)
• Treatment of Hypertension
• Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
• Asymptomatic Carotid Artery Plaque Study (ACAPS)